Intravenous Steroid Injection for Treating Ear DisorderAs per a recent study, steroid treatment is an effective form of treatment for patients suffering from sudden sensorineural hearing loss (SSNHL). It initially occurs in one ear and generally causes a 30+ decibel (dB) hearing loss at three consecutive frequencies within a time period of three days.

Scientists from Spain presented a new study which evaluated the effect of intratympanic steroid injections in patients with SSNHL. Studies was conducted on 50 patients diagnosed with unilateral (affecting one ear) SSNHL due to unidentified reasons. Hearing improvement of 15 dB or more in PTA was noted in 32 cases (64 percent) by the intravenous treatment.

There were no statistical differences in age, sex ratio, time of onset to therapy, presence of vertigo and tinnitus, initial hearing level, and final hearing level after intravenous treatment between the two groups.

The intratympanic methylprednisolone significantly improved the outcome of SSNHL by non-randomized clinical trial showed after intravenous steroid treatment. The therapy including intratympanic steroids was termed as a useful and safe therapy for SSNHL cases that are refractory to standard treatments.

Randomized prospective clinical trials were defined as the researchers suggested that the number of injections, the types of steroids, and the most adequate doses must be definite in their nature. Evidence-based treatment for idiopathic SSNHL was also established by this study. Evaluated results compared initial therapy for SSNHL and steroids that were administrated systemically or by intratympanic injections were mush effective.